advanced search

Welcome: Guest

log in

HandyLab, Inc. Product Pipeline Analysis

Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 28
ISBN Number not applicable
Product Code GMD04726
Buy this product or for assistance call +44 20 7060 7474

Summary

This report is an insightful source for data, analysis and strategic insights into a HandyLab, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reason to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Company Overview
    • 2.1 Key Information
    • 2.2 Industry Outlook - In Vitro Diagnostics
  • 3 HandyLab, Inc. Pipeline Products
    • 3.1 HandyLab, Inc. Product Pipeline Analysis
      • 3.1.1 HandyLab, Inc. Pipeline Products By Equipment Type
      • 3.1.2 HandyLab, Inc. Pipeline Products By Development Stage
      • 3.1.3 HandyLab, Inc. Pipeline Products By Therapy Area
    • 3.2 Trichomonas Nucleic acid assay
      • 3.2.1 Product Description
      • 3.2.2 Product Status
    • 3.3 EBV Nucleic acid assay
      • 3.3.1 Product Description
      • 3.3.2 Product Institution Details
      • 3.3.3 Product Status
    • 3.4 JC Nucleic acid assay
      • 3.4.1 Product Description
      • 3.4.2 Product Institution Details
      • 3.4.3 Product Status
    • 3.5 BK Nucleic acid assay
      • 3.5.1 Product Description
      • 3.5.2 Product Institution Details
      • 3.5.3 Product Status
    • 3.6 CMV Nucleic acid assay
      • 3.6.1 Product Description
      • 3.6.2 Product Institution Details
      • 3.6.3 Product Status
    • 3.7 HHV6 Nucleic acid assay
      • 3.7.1 Product Description
      • 3.7.2 Product Institution Details
      • 3.7.3 Product Status
    • 3.8 HSV Nucleic acid assay
      • 3.8.1 Product Description
      • 3.8.2 Product Institution Details
      • 3.8.3 Product Status
    • 3.9 Jaguar
      • 3.9.1 Product Description
      • 3.9.2 Product Institution Details
      • 3.9.3 Product Status
    • 3.10 GBS Nucleic acid assay
      • 3.10.1 Product Description
      • 3.10.2 Product Institution Details
      • 3.10.3 Product Status
    • 3.11 NG Nucleic acid assay
      • 3.11.1 Product Description
      • 3.11.2 Product Institution Details
      • 3.11.3 Product Status
    • 3.12 CT Nucleic acid assay
      • 3.12.1 Product Description
      • 3.12.2 Product Institution Details
      • 3.12.3 Product Status
    • 3.13 Lynx
      • 3.13.1 Product Description
      • 3.13.2 Product Institution Details
      • 3.13.3 Product Status
    • 3.14 Real Time PCR System
      • 3.14.1 Product Description
      • 3.14.2 Product Institution Details
      • 3.14.3 Product Status
  • 4 Major Products and Services
    • 4.1 Overview
  • 5 Key Employees
  • 6 Locations And Subsidiaries
    • 6.1 Head Office
  • 7 Financial Deals Landscape
    • 7.1 Venture Financing
      • 7.1.1 HandyLab Completes $5.6 Million Private Equity Financing
  • 8 Appendix
    • 8.1 Methodology
      • 8.1.1 Coverage
      • 8.1.2 Secondary Research
      • 8.1.3 Primary Research
      • 8.1.4 Expert Panel Validation
    • 8.2 Contact Us
    • 8.3 About Global Markets Direct
    • 8.4 Disclaimer
  • List of Tables
    • Table 1: HandyLab, Inc.,Key Facts
    • Table 2: HandyLab, Inc. Pipeline Products by Equipment Type
    • Table 3: HandyLab, Inc. Pipeline Products By Development Stage
    • Table 4: HandyLab, Inc. Pipeline Products By Therapy Area
    • Table 5: HandyLab, Inc., Key Employees,
  • List of Figures
    • Figure 1: HandyLab, Inc. Pipeline Products By Equipment Type
    • Figure 2: HandyLab, Inc. Pipeline Products By Equipment Type
    • Figure 3: Global Markets Direct Methodology
Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Product features / use
Scope Expert Insight/Opinion yes
Features Primary Research Data yes

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>